Kairos Pharma, LTD. business relationships
Companies named in Kairos Pharma, LTD.’s 10-K filed 2026-03-31, and public companies whose annual reports name Kairos Pharma, LTD.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- <1 / 100 Top 6% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Layers: Peptides
Named in Kairos Pharma, LTD.’s annual report 2
“and Asia, raised $100 million in equity, and set up partnerships with Merck, Fosun Pharma, Tasly Pharma, and Kalbe Pharma.” SEC filing
“company that partnered with Pfizer, MedImmune, and Isu Abxis.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.